MP0310

A bad day for Molecular Partners
EP Vantage
Wed, 04/27/22 - 10:45 am
Molecular Partners
MP0310
Amgen
Novartis
ensovibep
Amgen pays $50M for Molecular Partners’ preclinical bispecific
Fierce Biotech
Wed, 12/19/18 - 10:07 am
Amgen
Molecular Partners
MP0310